Patent details

Basic Information

Publication number:

EP3283058

PCT Application Number:

IB2016052136

Type:

European Patent Granted for LU

Legal Status:

Lapsed

Application number:

EP167180207

PCT Publication Number:

WO2016166703

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

RIBOCICLIB TABLET

French Title of Invention:

COMPRIMÉ DE RIBOCICLIB

German Title of Invention:

RIBOCICLIB-TABLETTE

SPC Number:

Dates

Filing date:

14/04/2016

Grant date:

16/11/2022

EP Publication Date:

21/02/2018

PCT Publication Date:

20/10/2016

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

16/11/2022

EP B1 Publication Date:

16/11/2022

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

14/04/2023

Expiration date:

14/04/2036

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

09/11/2022

 

 

Name:

Novartis AG

Address:

Lichtstrasse 35, 4056 Basel, Switzerland (CH)

Inventor

1

Name:

COSTA, Rui

Address:

Switzerland (CH)

2

Name:

GURURAJAN, Bindhumadhavan

Address:

Switzerland (CH)

3

Name:

GRANDEURY, Arnaud

Address:

Switzerland (CH)

Priority

Priority Number:

201562148240 P

Priority Date:

16/04/2015

Priority Country:

United States (US)

Classification

IPC classification:

A61K 9/20;

Publication

European Patent Bulletin

1

Issue number:

202246

Publication date:

16/11/2022

Description:

Grant (B1)

2

Issue number:

202248

Publication date:

30/11/2022

Description:

Application number/publication number of the divisional application (Art. 76) changed

Annual Fees

Annual Fee Due Date:

Annual Fee Number:

Expected Payer:

Last Annual Fee Payment Date:

Last Annual Fee Paid Number:

Payer:

Filing date	Document type	Number of pages